Sinclair Pharma

Sinclair Pharma is an international specialty pharmaceutical company centred on Dermatology, in particular Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners. Sinclair Pharma plc is listed on the London Stock Exchange AIM market
London, GB
Size (employees)
182 (est)
Sinclair Pharma was founded in 1971 and is headquartered in London, GB

Sinclair Pharma Office Locations

Sinclair Pharma has offices in London, Frankfurt am Main, Paris, San Fernando de Henares and in 1 other location
London, GB (HQ)
Whitfield Court 26-28 Whitfield St
Cheshire West and Chester, GB
Office Village
San Fernando de Henares, ES
Parque Empresarial de San Fernando. Ed Dublin planta 2
Paris, FR
46 Rue de la Bienfaisance
Frankfurt am Main, DE
1 Westhafenpl.

Sinclair Pharma Data and Metrics

Sinclair Pharma Financial Metrics

Sinclair Pharma's revenue was reported to be £75.9 m in FY, 2015 which is a 19% increase from the previous period.

Revenue (FY, 2015)

75.9 m

Revenue growth (FY, 2014 - FY, 2015), %


Gross profit (FY, 2015)

47.8 m

Gross profit margin (FY, 2015), %


Net income (FY, 2015)

(7.2 m)

Market capitalization (24-Jul-2017)

149.4 m

Closing share price (24-Jul-2017)


Cash (30-Jun-2015)

12.7 m
Sinclair Pharma's current market capitalization is £149.4 m.
GBPFY, 2013FY, 2014FY, 2015


55.4 m63.6 m75.9 m

Revenue growth, %


Cost of goods sold

21.7 m27.8 m28.1 m

Gross profit

33.6 m35.8 m47.8 m

Gross profit Margin, %


Operating expense total

49 m37.5 m43.2 m

Pre tax profit

(17 m)(4.4 m)(8.2 m)

Net Income

(15.8 m)(4.1 m)(7.2 m)
GBPFY, 2013FY, 2014FY, 2015


5.1 m17.5 m12.7 m

Accounts Receivable

16.9 m25.2 m24.5 m

Current Assets

29.8 m55.8 m47.9 m


4.8 m5.4 m5.2 m


121.4 m241.5 m232.3 m

Total Assets

156 m302.7 m285.4 m

Accounts Payable

8.7 m14.6 m12.6 m

Current Liabilities

24 m42.9 m46.7 m

Total Liabilities

45.5 m184.8 m179.8 m

Retained Earnings

(15.8 m)(5.3 m)(7.2 m)

Total Equity

110.5 m117.9 m105.6 m

Financial Leverage

1.4 x2.6 x2.7 x
GBPFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

969 k(6.8 m)4.3 m

Cash From Financing Activities

7.4 m63.6 m(982 k)

Income Taxes Paid

1.1 m348 k944 k
Y, 2015

Financial Leverage

2.7 x

Sinclair Pharma Operating Metrics

Sinclair Pharma's Training Provided, no. of people was reported to be 300 in FY, 2016
FY, 2016

Training Provided, no. of people


    Sinclair Pharma Market Value History

    Traffic Overview of Sinclair Pharma

    Sinclair Pharma Company Life and Culture

    You may also be interested in